Related Experiment Video
Updated: Apr 14, 2026
06:25
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
Published on: February 23, 2024
1.3K
Discrepancy between Visual Acuity and Microperimetry in AMD Patients: Visual Acuity Appears as an Inadequate
1Inflammatory and Retinal Eye Diseases, Centre for Ophthalmic Specialised Care, Lausanne, Switzerland.
Klinische Monatsblatter Fur Augenheilkunde
|April 23, 2015
Summary
Best corrected visual acuity (BCVA) may not reflect true macular function in age-related macular degeneration (AMD). Microperimetry testing is crucial for accurately assessing visual impairment in AMD patients.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Diagnostic Tools
Background:
- Best corrected visual acuity (BCVA) in age-related macular degeneration (AMD) patients can be misleading.
- Good BCVA may mask significant macular dysfunction and visual handicap.
Purpose of the Study:
- To evaluate the correlation between BCVA and microperimetry results in AMD patients.
- To highlight the utility of microperimetry in assessing macular function.
Main Methods:
- Retrospective analysis of 233 AMD patient files.
- Microperimetry data analyzed for 82 patients.
- Comparison of BCVA with microperimetry performance.
Main Results:
- 39% of patients with BCVA ≥ 0.8 had microperimetry below 200/560 db.
- 12.2% of patients exhibited very poor microperimetry (< 120/560 db) despite good BCVA.
- Significant discrepancy between visual acuity and macular function observed.
Conclusions:
- Over a third of AMD patients show poor macular function despite good BCVA.
- Microperimetry is essential for accurate assessment of macular function in AMD.
- Visual acuity alone can be misleading in managing AMD patients.
